Download Free Sample Report

This report contains market size and forecasts of Migraine Drugs in global, including the following market information:

• Global Migraine Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Migraine Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Migraine Drugs companies in 2021 (%)

The global Migraine Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sumatriptan Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Migraine Drugs include Allergan, Merck, Pfizer, Teva, Pfizer, Johnson & Johnson, Endo International, GlaxoSmithKline and Impax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Migraine Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Migraine Drugs Market Segment Percentages, by Type, 2021 (%)

• Sumatriptan
• Zolmitriptan
• Rizatriptan
• Others Drug

Global Migraine Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Migraine Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Household Use
• Others

Global Migraine Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Migraine Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Migraine Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Migraine Drugs revenues share in global market, 2021 (%)
• Key companies Migraine Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Migraine Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Merck
• Pfizer
• Teva
• Pfizer
• Johnson & Johnson
• Endo International
• GlaxoSmithKline
• Impax
• Abbott
• Bayer
• Eli Lilly
• Ethypharm
• Kowa Pharmaceuticals America
• Winston Pharmaceuticals
• AstraZeneca